ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
01/29/2026
Back to search
Official data from USPTO
ICHALIG
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
01/30/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
11/21/2018
Registration date
03/31/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/31/2020
Last transaction
01/30/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
CN
Examiner
SAKAI, ADA HAN
Law office
L60
Current location
TMEG LAW OFFICE 106
Holders and representatives
Holders
Bio-Thera Solutions, Ltd.
Bio-Thera Solutions, Ltd.
Representatives
Zhi Dong Hamre, Schumann, Mueller & Larson, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of cancertumorautoimmune diseasesdiabetescardiovascular diseasesophthalmic diseases; chemical preparations for pharmaceutical purposes for the prevention and treatment of cancertumorautoimmune diseasesdiabetescardiovascular diseasesophthalmic diseases; Biological preparations for medical purposes for the prevention and treatment of cancertumorautoimmune diseasesdiabetescardiovascular diseasesophthalmic diseases; injectable pharmaceutical preparations for the prevention and treatment of cancertumorautoimmune diseasesdiabetescardiovascular diseasesophthalmic diseases; medicines for use in human for the prevention and treatment of cancertumorautoimmune diseasesdiabetescardiovascular diseasesophthalmic diseases
Publications
History of USPTO decisions and trademark events.
32 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/31/2025
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
02/25/2021
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
02/24/2021
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
12/23/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/08/2020
ES7R
TEAS SECTION 7 REQUEST RECEIVED
09/03/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/29/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/06/2020
FIMP
FINAL DISPOSITION PROCESSED
08/06/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/30/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
03/31/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/14/2020
PUBO
PUBLISHED FOR OPPOSITION
01/14/2020
GPNX
NOTIFICATION PROCESSED BY IB
01/10/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/25/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/25/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/25/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/11/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/06/2019
ALIE
ASSIGNED TO LIE
12/05/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/26/2019
RFNT
REFUSAL PROCESSED BY IB
06/14/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/30/2019
RFRR
REFUSAL PROCESSED BY MPU
05/30/2019
MAFR
APPLICATION FILING RECEIPT MAILED
05/07/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/04/2019
CNRT
NON-FINAL ACTION WRITTEN
05/03/2019
DOCK
ASSIGNED TO EXAMINER
05/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/03/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/02/2019
Continuous trademark protection
Get notified about every new filing that threatens ICHALIG or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.